Why is Clearpoint Neuro, Inc. ?
- INTEREST(HY) At USD 2.79 MM has Grown at 3,393.75%
- OPERATING CASH FLOW(Y) Lowest at USD -30.19 MM
- ROCE(HY) Lowest at -226.52%
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 24.98%, its profits have fallen by -35.1%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Clearpoint Neuro, Inc. for you?
High Risk, High Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
At USD 23.01 MM has Grown at 29.99%
Higher at USD -20.89 MM
Highest at 2.15 times
Fallen by 0.84% (YoY
At USD 2.79 MM has Grown at 3,393.75%
Lowest at USD -30.19 MM
Lowest at -226.52%
Lowest at USD -11.38 MM
Lowest at USD -11.34 MM
Highest at 320.93 %
Lowest at USD -8.87 MM
Lowest at -81.53 %
Lowest at USD -0.38
Here's what is working for Clearpoint Neuro, Inc.
Net Sales (USD MM)
Inventory Turnover Ratio
Raw Material Cost as a percentage of Sales
Depreciation (USD MM)
Here's what is not working for Clearpoint Neuro, Inc.
Interest Paid (USD MM)
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
Operating Cash Flows (USD MM)
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
Operating Profit (USD MM)
Operating Profit to Sales
EPS (USD)
Debt-Equity Ratio






